TEK DOZ ORTA ETKİLİ KAS GEVŞETİCİLERE BAĞLI POSTOPERATİF REZİDÜEL NÖROMUSKÜLER BLOK İNSİDANSI VE ETKİ EDEN FAKTÖRLER
AMAÇ:Bu çalışmanın amacı sağlıklı, erişkin hastalarda endotrakeal entübasyon için uygulanan tek doz orta etkisüreli kas gevşeticilerine (atrakuryum, vekuronyum ve rokuronyum) bağlı erken postoperatif rezidüelnöromusküler blok (PRNB) insidansını ve buna etki eden sonra faktörleri araştırmaktır.GEREÇ ve YÖNTEM:Çalışma prospektif, gözlemsel olarak, anestezi sırasında sadece endotrakealentübasyonu kolaylaştırmak için tek doz vekuronyum, atrakuryum veya rokuronyum kullanılan ve ameliyatbittikten sonra derlenme odasına alınan hastalarda yapıldı. Derlenme odasında akselomiyograf ile nöromuskülerileti monitorize edildi ve dörtlü uyarıya yanıt (TOF) oranı ölçüldü; 0,9'un altındaki değerler “PRNB var” olarakkaydedildi. Hastalara kullanılan anestezikler ve kas gevşeticisinin seçimi, antidot (neostigmin) kullanımı,ekstübasyon ve derlenme odasına alınma kararları hastayı takip eden anestezi doktoruna bırakıldı. Yaş, kilo,cinsiyet, antidot kullanımı, anestezi süresi, ekstübasyondan sonra derlenme odasına alınma süreleri PRNB içinrisk faktörü olarak alındı, stepwise lojistik regresyon analizi yapıldı.BULGULAR:Çalışmaya 84 hasta alındı, vekuronyum, atrakuryum, rokuronyum kullanılan hasta sayısısırasıyla 29, 28, 27 oldu. Hastaların % 58,3'ne neostigmin yapıldı. Medyan anestezi süresi 80 dakikaydı.Derlenme odasında PRNB insidansı (TOF<0,90) % 13,1 bulundu. Regresyon analizinde cinsiyetin PRNB'uetkilediği; kadın cinsiyetin, PRNB riskini artırdığı bulundu (OR: 7,250, %95 CI:1,019-51,593). Diğer riskfaktörlerinin PRNB'a anlamlı etkisi saptanmadı.SONUÇ:Klinik olarak ameliyat nedeni dışında ek risk faktörü taşımayan ve anestezi süresi bir saatten uzun olanhastalarda, “cinsiyet” tek doz orta etkili kas gevşeticilerine bağlı PRNB insidansını etkileyebilir
The Incidence of Residual Neuromuscular Blockade Associated with Single Dose of Intermediate-acting Non-depolarizing Neuromuscular Blocking
PURPOSE: The goal of this study is to investigate the incidence of postoperative residual neuromuscular blockade (PRNB) associated with single-dose intermediate-acting muscle relaxants (atracurium, vecuronium, rocuronium) administered to adult patients for endotracheal intubation during early postoperative period and subsequent factors affecting this. MATERIALS and METHODS: This prospective and observational study was conducted after obtaining the permission of the local ethics committee. Adult, ASA I, II patients who received a single dose of vecuronium, atracurium or rocuronium during general anesthesia for elective surgical procedure were included in the study. The decisions about the anesthetics and muscle relaxants used on the patients, reversal with neostigmine, extubation and transfer to the recovery room were left to be made by the anesthesiologist following the patient. The patient who was taken into the recovery room had neuromuscular monitoring using accelomyography. Train-of-four (TOF) ratios under 0.9 were recorded as “PRNB present”. Age, weight, gender, reversal, anesthesia duration, time for transfer to the recovery room after extubation were considered risk factors for PRNB, stepwise logistic regression analysis was conducted. RESULTS: This study included 84 patients and the number of patients that were given vecuronium, atracurium, rocuronium were 29, 28, and 27, respectively. After the end of the operation, reversal was performed with neostigmine in 58.3% of the patients. The median length of anesthesia was 80 minutes. PRNB incidence (TOF<0.90) in the recovery room was determined to be 13.1%. Based on the regression analysis, gender was determined to affect PRNB; female gender increased PRNB risk (OR: 7.250, 95%, CI:1.019-51.593). The remaining factors did not have any significant effect on PRNB. CONCLUSION: In patients who do not have other risk factors in addition to the operation reason and whose anesthesia duration is longer than one hour, “gender” may affect PRNB incidence associated with single-dose intermediate-acting muscle relaxants.
___
- 1. Murphy GS, Brull SJ. Residual neuromuscular block:
Lessons unlearned. Part I: Definitions, incidence, and
adverse physiologic effects of residual neuromuscular
block.AnesthAnalg 2010;111:120-8.
- 2. Naguib M. Pharmacology of muscle relaxant and their
antagonist neuromuscular physiology and
pharmacology. In: Miller RD, ed. Anaesthesia. 6 ed.
Philadelphia, Churchil Livingston, 2006:481-572.
- 3. Murphy GS. Residual neuromuscular blockade:
incidence, assessment, and relevance in the
postoperative period. Minevra Anestesiol 2006;72:97-
109.
- 4. Murphy GS, Szokol JW, Marymont JH, Greenberg SB,
Avram MJ, Vender JS. Residual neuromuscular
blockade and critical respiratory events in the
postanesthesia care unit. Anesth Analg 2008;107:130-
7.
- 5. Murphy GS, Szokol JW, Franklin M, Marymont JH,
Avram MJ, Vender JS. Postanesthesia Care unit
recovery times and neuromuscular blocking drugs: a
prospective study of orthopedic surgical patients
randomized to receive pancuronium or rocuronium.
AnesthAnalg 2004;98:193-200.
- 6. Eikermann M, Groeben H, Hüsing J, Peters J.
Accelerometry of adductor pollicis muscle predicts
recovery of respiratory function from neuromuscular
blockade.Anesth 2003;98:1333-7.
- 7. Eriksson LI, Satoo M, Severinghaus JW. Effect of
vecuronium induced partial neuromuscular block on
hipoxic ventilatory response.Anesth 1993;78:693-9.
- 8. Naguib M, Kopman AF, Ensor JE. Neuromuscular
monitoring and postoperative residual curarisation: a
meta-analysis. Br JAnaesth 2007;98:302-16.
- 9. Tsai CC, Chung HS, Chen PL, Yu CM, Chen MS, Hong
CL. Postoperative residual curarization: Clinical
observation in the post-anesthesia care unit. Chang
Gung Med J 2008;31:364-8,
- 10. Houghton IT, Aun CS, Oh TE. Vecuronium: an
anthropometric comparison.Anaesth 1992;47:741-6.
- 11. Semple P, Hope DA, Clyburn P, Rodbert A. Relative
potency of vecuronium in male and female patients in
Britain andAustralia. Br JAnaesth 1994;72:190-4.
- 12. Xue F, Liao X, Liu J et al. Dose-response curve and
timecourse of effect of vecuronium in male and female
patients. Br JAnaesth 1998;80:720-4.
- 13. Xue FS, An G, Liao X, Zou Q, Luo LK. The
pharmacokinetics of vecuronium in male and female
patients.AnesthAnalg 1998;86:1322-7.
- 14. M. Adamus, T. Gabrhelik, O. Marek. Influence of
gender on the course of neuromuscular block following
a single bolus dose of cisatracurium or rocuronium. Eur
JAnaesth 25: 589595
- 15. Xue FS, Tong SY, Liao X, Liu JH, An G, Luo LK.
Doseresponse and time course of effect of rocuronium
in male and female anesthetized patients. Anesth Analg
1997;85:667-71.
- 16. Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex
and anaesthetic technique on the pharmacokinetics of
atracurium. Br JAnaesth 1992;69:439-43
- 17. Xue FS, Zhang YM, Liao X, Liu JH, An G. Influences
of age and gender on dose response and time course of
effect of atracurium in anesthetized adult patients. J
ClinAnesth 1999;11:397-405.
- 18. Alkhazrajy W, Khorasanee AD, Russell WJ. Muscle
weakness after muscle relaxants: an audit of clinical
practice.Anaesth Intens Care 2004;32:256-9.
- 19. Berg H, Roed J, Viby-Mogensen J, et al. Residual
neuromuscular block is a risk factor for postoperative
pulmonary complications. A prospective, randomised,
and blinded study of postoperative pulmonary
complications after atracurium, vecuronium and
pancuronium. Acta Anaesthesiol Scand 1997;41:1095-
103.
- 20. Brull Sorin J. Naguib Mohamed, Miller Ronald D.
Residual neuromuscular block: Rediscovering the
obvious. AnestAnalg 2008; 107:11-14.
- 21. Miller RD, Ward TA. Monitoring and pharmacologic
reversal of a nondepolarizing neuromuscular blockade
should be routine.AnestAnalg 2010;111:3-5
- 22. Brull SJ, Murphy GS. Residual neuromuscular block:
lessons unlearned. Part II: methods to reduce the risk of
residual weakness.AnesthAnalg 2010;111:129-40.
- 23. Viby-Mogensen J. Postoperative residuel curarization
and evidence-based anaesthesia. Br J Anaesth
2000;84:301-2.
- 24. Bevan DR, Smith C, Donati F. Postoperative
neuromuscular blockade: A comparison between
atracurium, vecuronium, and pancuronium.
Anesthesiology 1988;69:272-6
- 25. McCaul C, Tobin E, Boylan JF, McShane AJ.
Atracurium is associated with postoperative residual
curarization. Br JAnaesth 2002; 89:766-9.
- 26. Debaene B, Plaud B, Dilly MP, Donati F. Residual
paralysis in the PACU after a single intubating dose of
nondepolarizing muscle relaxant with an intermedi